AzTrials
AzTrials

Endothelial FunctionNCT05451641

Blood Flow Restriction Resistance Training Intervention on Vascular Function

A study testing Blood flow restriction resistance training in people with Endothelial Function, run by Hirofumi Tanaka at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to investigate the effect of blood flow restriction (BFR) resistance training on vascular function. The investigators aim to compare the effects of different BFR devices (wide-rigid cuffs and narrow elastic bands) on vascular function. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Endothelial Function
What is being tested?
Blood flow restriction resistance training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
26 participants
Where
1 siteUnited States
Study dates
20 Sep 2022to 19 Sep 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Apparently healthy, sedentary or recreationally active young adults aged between 18 - 40 years old and signed the informed consent.

Who cannot join

  • A current COVID-19 diagnosis
  • morbid obesity
  • hypertension
  • smoking
  • overt cardiovascular disease
  • using any medication that might affect the cardiovascular system
  • current participation in resistance training.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Cardiovascular Aging Research Laboratory

    Austin, Texas, 78705

Other trials in United States

About this study

Official title: The Effect of Blood Flow Restriction Resistance Training on Vascular Function: Wide-Rigid Cuffs vs. Narrow-Elastic Bands

The purpose of this study is to investigate the effect of blood flow restriction (BFR) resistance training on vascular function. The investigators aim to compare the effects of different BFR devices (wide-rigid cuffs and narrow elastic bands) on vascular function. The investigators hypothesize that BFR resistance training with wide-rigid cuffs might have a minor negative effect (short-term and reversible) on vascular function, while BFR resistance training with narrow-elastic bands may improve vascular function. Both training methods are equally effective in increasing muscle strength.

Read the detailed description

Blood flow restriction (BFR) resistance training has been proven to be effective in increasing muscle mass and strength. During BFR training, cuffs (similar to blood pressure cuffs) are placed on the proximal ends of the extremities to partially occlude arterial blood flow to the working muscles and fully restrict venous outflow from the working muscle. The metabolites produced by the working muscle during exercise are trapped in the working muscle, which causes metabolic stress to augment muscle adaptation. Typically, two types of cuffs are used in the BFR training: the narrow-elastic bands and wide-rigid nylon cuffs adapted from surgical tourniquets and blood pressure cuffs.

Currently, the effect of BFR training on vascular function remains unclear. When the cuffs are removed after BFR training, there will be a reactive hyperemic blood flow to wash out all the metabolites produced during exercise. This reactive hyperemic blood flow also will impose shear stress on the arterial vessel wall. The shear stress will lead to an increase in vasodilator factors, which lead to an improvement in vascular function. However, other studies have pointed out that BFR training might cause a negative effect on vascular function when the occlusion pressure was too high. The possible mechanisms of the negative effect might be ischemia-reperfusion injury and retrograde shear stress in the artery. The wide-rigid cuffs are easily available but have the potential to inhibit the expansion of muscle upon increased blood flow accompanying exercise and muscle contraction while the narrow-elastic bands do not prevent the expansion. To the investigators' best knowledge, there is no study directly comparing different BFR cuffs on vascular function. Thus, the aim of the present study is to compare the effects of different BFR cuffs on vascular function (evaluated by flow-mediated dilation, a non-invasive measure of endothelial-derived vasodilation).

Being tested
Blood flow restriction resistance training

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Blood flow restriction resistance trainingBehavioural

    The participants will receive a 2-week exercise training program (3 times per week). Each training session will consist of 3 resistance training exercises with two blood flow restriction devices (wide-rigid cuff and narrow-elastic band). For both arms, the participants will perform the same exercise with different BFR devices.

Study groups in NCT05451641
Study groupRoleWhat they receive
Wide-rigid cuffExperimentalThe wide-rigid cuff will be randomly assigned to one of the subject's arms.
Receives: Behavioral: Blood flow restriction resistance training
Narrow-elastic bandExperimentalThe narrow-elastic band will be randomly assigned to another arm of the subject.
Receives: Behavioral: Blood flow restriction resistance training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline vascular function at 2 weeks

    Flow-mediated dilation evaluated by an ultrasound machine

    Measured: Baseline measurement and measurement at 2 weeks

  2. Change from baseline muscle strength at 2 weeks

    Measured by a cable machine in the gym

    Measured: Baseline measurement and measurement at 2 weeks

  3. Change from baseline grip strength at 2 weeks

    Measured by a hand dynamometer

    Measured: Baseline measurement and measurement at 2 weeks

Secondary outcomes (10)
  1. Change from baseline body fat percentage at 2 weeks

    Measured by a bioelectrical impedance analysis machine

    Measured: Baseline measurement and measurement at 2 weeks

  2. Change from baseline fat mass at 2 weeks

    Measured by a bioelectrical impedance analysis machine

    Measured: Baseline measurement and measurement at 2 weeks

  3. Change from baseline lean body mass at 2 weeks

    Measured by a bioelectrical impedance analysis machine

    Measured: Baseline measurement and measurement at 2 weeks

  4. Blood flow responses to different types of cuff

    Measured by an ultrasound machine

    Measured: Baseline measurement

  5. Blood flow responses to different types of cuff

    Measured by an ultrasound machine

    Measured: At 2 weeks

  6. Change from baseline arterial stiffness at 2 weeks

    Evaluated by the Omron VP-1000plus device (Non-invasive measurement)

    Measured: Baseline measurement and measurement at 2 weeks

  7. Change from baseline blood lactate concentration

    Measured by a lactometer

    Measured: At 10 minutes before the training sessions (baseline measurement) and at 10 minutes after the training sessions

  8. Changes from baseline heart rate at the end of each exercise during all the training sessions

    Measured by a heart rate monitor

    Measured: At 10 minutes before the training sessions (baseline measurement), at 10 minutes, 20 minutes, and 30 minutes during the training sessions

  9. Change from baseline blood pressure at the end of each exercise during all the training sessions

    Measured by an Omron digital blood pressure monitor

    Measured: At 10 minutes before the training sessions (baseline measurement), at 10 minutes, 20 minutes, and 30 minutes during the training sessions

  10. Change of the perceived exertion

    Borg rating of perceived exertion scale

    Measured: At 10 minutes, 20 minutes, and 30 minutes during the training sessions

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jul 2022
  2. Study start20 Sep 2022
  3. Primary completion1 Sep 2024
  4. Study completion19 Sep 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05451641
Sponsor's protocol ID
STUDY00002999
Status last verified
Dec 2024
First submitted
22 Jun 2022
Last updated
10 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Lixandrao ME, Ugrinowitsch C, Berton R, Vechin FC, Conceicao MS, Damas F, Libardi CA, Roschel H. Magnitude of Muscle Strength and Mass Adaptations Between High-Load Resistance Training Versus Low-Load Resistance Training Associated with Blood-Flow Restriction: A Systematic Review and Meta-Analysis. Sports Med. 2018 Feb;48(2):361-378. doi: 10.1007/s40279-017-0795-y.

    PubMed 29043659
  • Pearson SJ, Hussain SR. A review on the mechanisms of blood-flow restriction resistance training-induced muscle hypertrophy. Sports Med. 2015 Feb;45(2):187-200. doi: 10.1007/s40279-014-0264-9.

    PubMed 25249278
  • Early KS, Rockhill M, Bryan A, Tyo B, Buuck D, McGinty J. EFFECT OF BLOOD FLOW RESTRICTION TRAINING ON MUSCULAR PERFORMANCE, PAIN AND VASCULAR FUNCTION. Int J Sports Phys Ther. 2020 Dec;15(6):892-900. doi: 10.26603/ijspt20200892.

    PubMed 33344005
  • Hunt JE, Galea D, Tufft G, Bunce D, Ferguson RA. Time course of regional vascular adaptations to low load resistance training with blood flow restriction. J Appl Physiol (1985). 2013 Aug 1;115(3):403-11. doi: 10.1152/japplphysiol.00040.2013. Epub 2013 May 23.

    PubMed 23703116
  • Horiuchi M, Okita K. Blood flow restricted exercise and vascular function. Int J Vasc Med. 2012;2012:543218. doi: 10.1155/2012/543218. Epub 2012 Oct 22.

    PubMed 23133756
  • Alhejily W, Aleksi A, Martin BJ, Anderson TJ. The effect of ischemia-reperfusion injury on measures of vascular function. Clin Hemorheol Microcirc. 2014;56(3):265-71. doi: 10.3233/CH-131741.

    PubMed 23719421
  • Thijssen DH, Dawson EA, Tinken TM, Cable NT, Green DJ. Retrograde flow and shear rate acutely impair endothelial function in humans. Hypertension. 2009 Jun;53(6):986-92. doi: 10.1161/HYPERTENSIONAHA.109.131508. Epub 2009 Apr 20.

    PubMed 19380611

Questions about this trial

What is this clinical trial studying?

A study testing Blood flow restriction resistance training in people with Endothelial Function, run by Hirofumi Tanaka at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline vascular function at 2 weeks (time frame: Baseline measurement and measurement at 2 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05451641, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jun 2026; AzTrials last refreshed its copy on 31 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in